Clinical trial
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention…
NCT00409708 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00409708 |
|---|---|
| Title | Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD) |
| Official title | An Open-label, Behavioral-treatment-controlled Evaluation of the Effects of Extended Release Methylphenidate on the Frequency of Cytogenetic Abnormalities in Children 6 - 12 Years of Age With Attention Deficit Hyperactivity Disorder (ADHD) |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy, Behavior Therapy |
| Enrollment | 142 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2008 |
| First posted | Dec 11, 2006 |
| Last update posted | May 17, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: